Evidence map›Paper›PMID 35481634›Full record

ArticleProtein science : a publication of the Protein Society2022

SPI "sandwich": Combined SUMO-Peptide-Intein expression system and isolation procedure for improved stability and yield of peptides.

Tess Lamer, Marco J van Belkum, Anjalee Wijewardane, Sorina Chiorean, Leah A Martin-Visscher, John C Vederas

Open access · greenAbstract read
In one paragraph

Article in Protein science : a publication of the Protein Society, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.3field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Design of Novel Saposin-like Bacteriocins Using a Hybrid Approach.Probiotics and antimicrobial proteins · 2025
    Article
  3. Solution Structure of the Broad-Spectrum Bacteriocin Garvicin Q.International journal of molecular sciences · 2025
    Article
  4. Article
  5. Article
  6. Microbiology spectrum · 2024
    Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Tess LamerDepartment of Chemistry, University of Alberta, Edmonton, Alberta, Canada.ORCID 0000-0002-1511-4540
Marco J van BelkumDepartment of Chemistry, University of Alberta, Edmonton, Alberta, Canada.ORCID 0000-0002-9296-6069
Anjalee WijewardaneDepartment of Chemistry, University of Alberta, Edmonton, Alberta, Canada.ORCID 0000-0002-8557-3718
Sorina ChioreanDepartment of Chemistry, University of Alberta, Edmonton, Alberta, Canada.ORCID 0000-0003-4801-7445
Leah A Martin-VisscherDepartment of Chemistry, The King's University, Edmonton, Alberta, Canada.ORCID 0000-0001-7307-9328
John C VederasDepartment of Chemistry, University of Alberta, Edmonton, Alberta, Canada.ORCID 0000-0002-2996-0326
University of Alberta · CAThe King's University · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recombinant peptide production in Escherichia coli is often accomplished through cloning and expression of a fusion protein. The fusion protein partner generally has two requirements: (a) it contains an affinity tag to assist with purification and (b) it can be cleaved off to leave only the desired peptide sequence behind. Common soluble fusion partners include small ubiquitin-like modifier protein (SUMO), maltose-binding protein (MBP), glutathione S-transferase (GST), or intein proteins. However, heterologously expressed peptides can suffer from proteolytic degradation or instability. This degradation can pose a major issue for applications requiring a large amount of purified peptide, such as NMR structural assignments or biochemical assays. Improving peptide yield by testing various expression and isolation conditions requires a significant amount of effort and may not lead to improved results. Here, we cloned and expressed four different peptides as SUMO fusion proteins. These peptides (lactococcin A, leucocin A, faerocin MK, neopetrosiamide A) were truncated during expression and isolation as SUMO fusions, resulting in low yields of purified peptide. To prevent this degradation and improve yield, we designed a new expression system to create a "sandwiched" fusion protein of the form: His

Indexed as

InteinsPeptidesEscherichia coliRecombinant Fusion ProteinsRecombinant ProteinsSmall Ubiquitin-Related Modifier ProteinsPeptidesRecombinant Fusion ProteinsRecombinant ProteinsSmall Ubiquitin-Related Modifier ProteinsbacteriocinEscherichia colifusion proteinheterologous expressionimproved yieldinteinpeptideproteolytic degradationpurificationsmall ubiquitin-like modifier

Identifiers

PMID35481634
PMCPMC9045064
OpenAlexW4224922638

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.